questionsmedicales.fr
États, signes et symptômes pathologiques
Signes et symptômes
Manifestations neurologiques
Troubles sensitifs
Troubles de l'audition
Perte d'audition
Surdité mixte de transmission et neurosensorielle
Surdité mixte de transmission et neurosensorielle : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Surdité mixte de transmission et neurosensorielle : Questions médicales les plus fréquentes",
"headline": "Surdité mixte de transmission et neurosensorielle : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Surdité mixte de transmission et neurosensorielle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-23",
"dateModified": "2025-04-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Surdité mixte de transmission et neurosensorielle"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Perte d'audition",
"url": "https://questionsmedicales.fr/mesh/D034381",
"about": {
"@type": "MedicalCondition",
"name": "Perte d'audition",
"code": {
"@type": "MedicalCode",
"code": "D034381",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.763.393.341"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Surdité mixte de transmission et neurosensorielle",
"alternateName": "Hearing Loss, Mixed Conductive-Sensorineural",
"code": {
"@type": "MedicalCode",
"code": "D046089",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Andrea Canale",
"url": "https://questionsmedicales.fr/author/Andrea%20Canale",
"affiliation": {
"@type": "Organization",
"name": "ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy."
}
},
{
"@type": "Person",
"name": "Valerio Bordino",
"url": "https://questionsmedicales.fr/author/Valerio%20Bordino",
"affiliation": {
"@type": "Organization",
"name": "ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy."
}
},
{
"@type": "Person",
"name": "Andrea Albera",
"url": "https://questionsmedicales.fr/author/Andrea%20Albera",
"affiliation": {
"@type": "Organization",
"name": "ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy."
}
},
{
"@type": "Person",
"name": "Anastasia Urbanelli",
"url": "https://questionsmedicales.fr/author/Anastasia%20Urbanelli",
"affiliation": {
"@type": "Organization",
"name": "ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy."
}
},
{
"@type": "Person",
"name": "Maria Gragnano",
"url": "https://questionsmedicales.fr/author/Maria%20Gragnano",
"affiliation": {
"@type": "Organization",
"name": "Department of Public Health Sciences and Paediatrics, University of Turin, Turin, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Joint Effects of Bisphenols and Iodine Exposure on Thyroid during Pregnancy.",
"datePublished": "2023-08-02",
"url": "https://questionsmedicales.fr/article/37571359",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/nu15153422"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bisphenols and alternative developers in thermal paper receipts from the U.S. market assessed by Fourier transform infrared spectroscopy.",
"datePublished": "2023-07-20",
"url": "https://questionsmedicales.fr/article/37481030",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.envpol.2023.122232"
}
},
{
"@type": "ScholarlyArticle",
"name": "The cost-effectiveness of dapagliflozin in heart failure with preserved or mildly reduced ejection fraction: A European health-economic analysis of the DELIVER trial.",
"datePublished": "2023-07-11",
"url": "https://questionsmedicales.fr/article/37344985",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ejhf.2940"
}
},
{
"@type": "ScholarlyArticle",
"name": "Methodological approaches for the assessment of bisphenol A exposure.",
"datePublished": "2023-07-07",
"url": "https://questionsmedicales.fr/article/37803563",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.foodres.2023.113251"
}
},
{
"@type": "ScholarlyArticle",
"name": "Are There Prevalent Sex Differences in Psychostimulant Use Disorder? A Focus on the Potential Therapeutic Efficacy of Atypical Dopamine Uptake Inhibitors.",
"datePublished": "2023-07-07",
"url": "https://questionsmedicales.fr/article/37446929",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules28135270"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Signes et symptômes",
"item": "https://questionsmedicales.fr/mesh/D012816"
},
{
"@type": "ListItem",
"position": 4,
"name": "Manifestations neurologiques",
"item": "https://questionsmedicales.fr/mesh/D009461"
},
{
"@type": "ListItem",
"position": 5,
"name": "Troubles sensitifs",
"item": "https://questionsmedicales.fr/mesh/D012678"
},
{
"@type": "ListItem",
"position": 6,
"name": "Troubles de l'audition",
"item": "https://questionsmedicales.fr/mesh/D006311"
},
{
"@type": "ListItem",
"position": 7,
"name": "Perte d'audition",
"item": "https://questionsmedicales.fr/mesh/D034381"
},
{
"@type": "ListItem",
"position": 8,
"name": "Surdité mixte de transmission et neurosensorielle",
"item": "https://questionsmedicales.fr/mesh/D046089"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Surdité mixte de transmission et neurosensorielle - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Surdité mixte de transmission et neurosensorielle",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Surdité mixte de transmission et neurosensorielle",
"description": "Comment diagnostiquer la surdité mixte ?\nQuels examens sont nécessaires ?\nQuels signes indiquent une surdité mixte ?\nPeut-on détecter la surdité mixte chez les enfants ?\nQuel spécialiste consulte-t-on pour ce diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Benzhydryl+Compounds&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Surdité mixte de transmission et neurosensorielle",
"description": "Quels sont les symptômes de la surdité mixte ?\nLa surdité mixte cause-t-elle des douleurs ?\nY a-t-il des signes d'alerte ?\nLes enfants montrent-ils des symptômes différents ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Benzhydryl+Compounds&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Surdité mixte de transmission et neurosensorielle",
"description": "Comment prévenir la surdité mixte ?\nLes protections auditives sont-elles utiles ?\nFaut-il éviter certains médicaments ?\nLes examens réguliers sont-ils nécessaires ?\nL'éducation sur la santé auditive est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Benzhydryl+Compounds&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Surdité mixte de transmission et neurosensorielle",
"description": "Quels traitements sont disponibles ?\nLes médicaments peuvent-ils aider ?\nQuand envisager une chirurgie ?\nLes appareils auditifs sont-ils efficaces ?\nY a-t-il des thérapies alternatives ?",
"url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Benzhydryl+Compounds&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Surdité mixte de transmission et neurosensorielle",
"description": "Quelles complications peuvent survenir ?\nLa surdité mixte peut-elle affecter la qualité de vie ?\nY a-t-il des risques de dépression ?\nLes complications sont-elles réversibles ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Benzhydryl+Compounds&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Surdité mixte de transmission et neurosensorielle",
"description": "Quels sont les facteurs de risque ?\nL'âge est-il un facteur de risque ?\nLes maladies chroniques influencent-elles ?\nLes traumatismes crâniens sont-ils un risque ?\nLes infections de l'oreille sont-elles un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Benzhydryl+Compounds&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la surdité mixte ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un audiogramme et des tests d'imagerie sont utilisés pour évaluer la perte auditive."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens cliniques, audiométriques et parfois une IRM sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une surdité mixte ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des difficultés à entendre dans des environnements bruyants et des sons étouffés."
}
},
{
"@type": "Question",
"name": "Peut-on détecter la surdité mixte chez les enfants ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests auditifs peuvent être réalisés dès la naissance pour détecter cette condition."
}
},
{
"@type": "Question",
"name": "Quel spécialiste consulte-t-on pour ce diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un oto-rhino-laryngologiste (ORL) est le spécialiste à consulter pour ce diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la surdité mixte ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent une perte auditive variable, des acouphènes et des difficultés de compréhension."
}
},
{
"@type": "Question",
"name": "La surdité mixte cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut causer des douleurs si des infections de l'oreille sont présentes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes d'alerte ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des difficultés soudaines à entendre ou des bruits étranges peuvent être des signes d'alerte."
}
},
{
"@type": "Question",
"name": "Les enfants montrent-ils des symptômes différents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent avoir des retards de langage ou des difficultés scolaires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées en raison de la dégénérescence."
}
},
{
"@type": "Question",
"name": "Comment prévenir la surdité mixte ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les bruits forts, traiter rapidement les infections de l'oreille et faire des bilans auditifs réguliers."
}
},
{
"@type": "Question",
"name": "Les protections auditives sont-elles utiles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles protègent contre les dommages auditifs dans des environnements bruyants."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certains médicaments ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments ototoxiques doivent être évités pour prévenir des dommages auditifs."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils nécessaires ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens auditifs réguliers aident à détecter précocement des problèmes auditifs."
}
},
{
"@type": "Question",
"name": "L'éducation sur la santé auditive est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sensibiliser à la santé auditive aide à prévenir des pertes auditives futures."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des appareils auditifs, des implants cochléaires et des interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour traiter des infections ou des inflammations associées."
}
},
{
"@type": "Question",
"name": "Quand envisager une chirurgie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée si des anomalies structurelles causent la perte auditive."
}
},
{
"@type": "Question",
"name": "Les appareils auditifs sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils améliorent souvent la capacité d'écoute, surtout dans des environnements calmes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies alternatives ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines thérapies alternatives peuvent aider, mais leur efficacité n'est pas toujours prouvée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles de l'équilibre, des infections récurrentes et des difficultés sociales."
}
},
{
"@type": "Question",
"name": "La surdité mixte peut-elle affecter la qualité de vie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des problèmes de communication et d'interaction sociale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de dépression ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la perte auditive peut augmenter le risque de dépression et d'anxiété."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être traitées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une prise en charge multidisciplinaire est souvent nécessaire pour gérer les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des infections fréquentes et l'exposition au bruit."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement augmente le risque de surdité mixte en raison de la dégénérescence auditive."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques influencent-elles ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète peuvent augmenter le risque de perte auditive."
}
},
{
"@type": "Question",
"name": "Les traumatismes crâniens sont-ils un risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traumatismes crâniens peuvent endommager les structures auditives et provoquer une surdité."
}
},
{
"@type": "Question",
"name": "Les infections de l'oreille sont-elles un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections récurrentes peuvent endommager l'oreille moyenne et interne, augmentant le risque."
}
}
]
}
]
}
The aim of this research was to study the combined effects of bisphenols and iodine exposure on the thyroid gland during pregnancy. We included 162 pregnant women from a cohort established in Shanghai...
Cash register receipts made of thermal paper expose workers and shoppers to endocrine-disrupting chemicals and contaminate paper recycling streams. In 2022, 571 receipts were collected from retail sto...
To determine the cost-effectiveness of dapagliflozin, added to usual care, in patients with heart failure (HF) with mildly reduced or preserved ejection fraction for the UK, German and Spanish payers ...
A lifetime Markov state-transition cohort model was developed. Quartiles of the Kansas City Cardiomyopathy Questionnaire total symptom score (KCCQ-TSS) defined health states and monthly transition cou...
Dapagliflozin, added to usual care, is very likely cost-effective for HF with mildly reduced or preserved ejection fraction in several European countries....
Bisphenol A (BPA) is an endocrine disruptor used in food contact materials, by the application of polycarbonate plastics and epoxy resins. The main objective of this study is to compare the estimate o...
Cross-sectional data of 13-years follow-up from a population-based birth cohort Generation XXI (GXXI) (n = 2804) and from the National Food, Nutrition and Physical Activity Survey (IAN-AF 2015-2016) (...
The "random forest" was found as the best methodology to estimate the daily BPA exposure (adolescents: RMSE = 0.989, MAE = 0.727, ρ = 0.168; adults: RMSE = 0.193, MAE = 0.147, ρ = 0.250). The median d...
The estimated daily BPA exposure strongly depends on the methodological approach. Food groups attribution may overestimate the exposure while the random forest appears to be a better methodological ap...
Psychostimulant use disorders (PSUD) affect a growing number of men and women and exert sizable public health and economic burdens on our global society. Notably, there are some sex differences in the...
Circulating antigen carbohydrate 125 (CA125) has emerged as a proxy of fluid overload in heart failure. This study aimed to evaluate the effect of dapagliflozin on short-term CA125 levels in patients ...
To evaluate the effect of dapagliflozin on body composition such as total body fat (BF) mass, abdominal visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) areas compared with glimepi...
This was a 52-week, multicentre, randomized, parallel-group, open-label, Phase IV (NCT02564926) study. Patients with inadequate glycaemic control (glycated haemoglobin ≥7.0% and <10.0%) on metformin m...
Of 124 enrolled patients from 14 centres, 121 received study treatment (dapagliflozin: 60; glimepiride: 61) and 106 (85.5%) completed the study. Over 52 weeks, the dapagliflozin group showed the follo...
Dapagliflozin reduced total BF mass, abdominal VAT and SAT areas, and showed better glycaemic control than glimepiride. Being safe and well-tolerated, dapagliflozin appears to be a more favourable alt...
This study aimed to investigate the effects of dapagliflozin on renal function of type 1 diabetes patients....
This retrospective multicenter cohort study enrolled 295 type 1 diabetes patients. The primary outcome was defined as the change in the estimated glomerular filtration rate (eGFR) after 24 months of d...
Finally, 255 patients were included in the final analysis (dapagliflozin group; 76 patients, non-use group; 179 patients), with a median eGFR of 74.0 mL/min/1.73 m...
At 24 months, the decline in eGFR was significantly lower in the dapagliflozin group than in the non-use group without increasing diabetic ketoacidosis and hypoglycemia....
Bisphenol A (BPA) can be metabolized by metabolic enzymes and may induce abnormal lipid metabolism. We hypothesized that BPA exposure and its interaction with metabolism-related genes might be associa...
Evidence suggests that adding dapagliflozin to the prior standard of care is cost-effective compared with the standard of care alone. The latest guideline by the American Heart Association/American Co...
To compare the cost-effectiveness of dapagliflozin and empagliflozin in treating HFrEF, we used a state-transition Markov model. This model was used to estimate the expected lifetime costs, quality-ad...
The base case analysis found that the incremental expected lifetime cost of treating patients with dapagliflozin vs empagliflozin was $37,684, resulting in an ICER of $44,763 per QALY. A price thresho...
The findings of this study indicate that dapagliflozin may offer greater lifetime economic value when compared with empagliflozin. Given that the current clinical practice guideline does not recommend...